Ebola Vaccine Trial Using Ring Strategy To Launch In Guinea; Researchers Learn From Ebola Doctor Vaccinated After Needlestick Injury

CIDRAP News: Ebola ring vaccination trial set for Guinea launch
“The World Health Organization (WHO) announced today that a phase 3 trial of a Canadian-developed Ebola vaccine will launch this week in Guinea, with a ring vaccination strategy designed to test if vaccines might be useful for stamping out hot spots in outbreak settings. In a separate development involving the same vaccine, a research team from the United States reported their experience using it to try to prevent Ebola infection in a doctor who sustained a needlestick injury while treating patients in Sierra Leone. The doctor tested negative for Ebola, but the effect of the vaccine was unclear, the report said…” (Schnirring, 3/5).

CNN: Potentially historic Ebola vaccine campaign to be launched in Guinea (Botelho, 3/5).
New York Times: A Mishap Sheds Light on an Ebola Vaccine (Grady, 3/5).
Reuters: Guinea to start final trials of Ebola vaccines this week (Kelland/Miles, 3/5).
U.N. News Centre: U.N. health agency announces start of Ebola vaccine testing in worst-affected areas of Guinea (3/5).
Wall Street Journal: New Ebola Vaccine to Be Tested in Guinea (Morse, 3/5).
WHO: Ebola vaccine efficacy trial ready to launch in Guinea (3/5).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.